SK
Sumeela Kasu
About Sumeela Kasu
Data last updated:
Sumeela Kasu is a Director at Concord Drugs Limited (since 2022). The company operates in Pharma. Concord Drugs Limited reported revenue of ₹45.26 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Concord Drugs Limited L24230TG1995PLC020093 | Director | 01 Jun 2022 | 1995 | ₹45.26 Cr (FY 2025) | Active |
Board colleagues of Sumeela Kasu
| Name | DIN | Company | Designation |
|---|---|---|---|
| Koni Reddy Seelam | 02829319 | Concord Drugs Limited | Whole-Time Director |
| Koni Reddy Seelam | Concord Drugs Limited | Cfo | |
| Nagavenkatahareeshkumar Solleti | 09066790 | Concord Drugs Limited | Director |
| Nagi Reddy Seelam | 01764665 | Concord Drugs Limited | Managing Director |
| Namratha | Concord Drugs Limited | Company Secretary | |
| Satyam Reddy Gopidi | 11282375 | Concord Drugs Limited | Director |
| Seelam Manojkumarreddy | 06991382 | Concord Drugs Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sumeela Kasu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sumeela Kasu
Sumeela Kasu currently holds 1 directorship: Concord Drugs Limited (Director, since 01 Jun 2022, revenue ₹45.26 Cr (FY 2025)).
Sumeela Kasu was first appointed on 01 Jun 2022 as Director at Concord Drugs Limited.
The current boards of Sumeela Kasu's companies include Koni Reddy Seelam (Concord Drugs Limited), Koni Reddy Seelam (Concord Drugs Limited), Nagavenkatahareeshkumar Solleti (Concord Drugs Limited), Nagi Reddy Seelam (Concord Drugs Limited), Namratha (Concord Drugs Limited), Satyam Reddy Gopidi (Concord Drugs Limited), among others.